115 related articles for article (PubMed ID: 15229677)
1. [Research and marketing].
Meland E; Hernborg A
Tidsskr Nor Laegeforen; 2004 Jul; 124(13-14):1820. PubMed ID: 15229677
[No Abstract] [Full Text] [Related]
2. Considerations in the treatment of mild-to-moderate hypertension.
Giaquinta D
Manag Care Interface; 2001 Mar; 14(3):80-1. PubMed ID: 11301960
[No Abstract] [Full Text] [Related]
3. Improving prescribing practices in primary care. A randomised trial and economic analysis of a multicomponent intervention showed small, but important, gains.
Del Mar C
PLoS Med; 2006 Jun; 3(6):e229. PubMed ID: 16729845
[TBL] [Abstract][Full Text] [Related]
4. [Isn't it good if one person out of 600 treated with statins will get better?].
Molander N
Lakartidningen; 2004 Jul; 101(28-29):2365. PubMed ID: 15291322
[No Abstract] [Full Text] [Related]
5. [Prevention of cardiovascular complications after a stroke or TIA: hypotensive and hypocholesterolemic therapy].
Vahl AC
Ned Tijdschr Geneeskd; 2004 Jul; 148(28):1408; author reply 1408-9. PubMed ID: 15291425
[No Abstract] [Full Text] [Related]
6. Economics of drug treatment.
Jackson PR
Lancet; 2002 Mar; 359(9309):892-3. PubMed ID: 11897317
[No Abstract] [Full Text] [Related]
7. [Marketing of researchers--lack of judgment or a new trend?].
Werkö L; Hernborg A; Liedholm H; Melander A
Lakartidningen; 2002 Apr; 99(17):1962-3. PubMed ID: 12043423
[No Abstract] [Full Text] [Related]
8. [Drug committees welcome the SBU hypertension report. A number of patients can be offered cost-effective, evidence-based therapy].
Ohlsson O
Lakartidningen; 2004 Dec; 101(49):3984-5. PubMed ID: 15633336
[No Abstract] [Full Text] [Related]
9. Hypertension hype.
Gorman C
Time; 2002 Dec 30-2003 Jan 6; 160(27):158. PubMed ID: 12528219
[No Abstract] [Full Text] [Related]
10. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
[TBL] [Abstract][Full Text] [Related]
11. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
[TBL] [Abstract][Full Text] [Related]
12. [Alfadil and heart failure--clinical conclusions do exist!].
Lohm L; Lindh E; Frösing R
Lakartidningen; 2003 Dec; 100(49):4112-3. PubMed ID: 14717078
[No Abstract] [Full Text] [Related]
13. [New lower cholesterol levels: How much does it cost? Who is to pay?].
Lindberg M
Ugeskr Laeger; 2004 Nov; 166(49):4493-4; author reply 4494. PubMed ID: 15626108
[No Abstract] [Full Text] [Related]
14. The not-so-hidden persuaders.
Harv Heart Lett; 1999 Oct; 10(2):6-7. PubMed ID: 10534813
[No Abstract] [Full Text] [Related]
15. [The "healthy" patient with hypercholesterolemia].
Klose G
Med Klin (Munich); 2005 Feb; 100(2):99-106; quiz 107-8. PubMed ID: 15711905
[No Abstract] [Full Text] [Related]
16. Beta-blockers and the treatment of hypertension.
Williams B
J Hypertens; 2007 Jul; 25(7):1351-3. PubMed ID: 17563554
[No Abstract] [Full Text] [Related]
17. [Ezetimibe=cost effectiveness. Science or a debate contribution from MSD?].
Lindberg M
Ugeskr Laeger; 2008 Sep; 170(38):2987; author reply 2988. PubMed ID: 18816890
[No Abstract] [Full Text] [Related]
18. [2008 National Cardiology Guidelines: Prioritization requires consideration to other factors than scientific studies alone].
Eklund K; Grip L; Israelsson B; Levin LA; Lindahl B; Wallentin L
Lakartidningen; 2008 May 7-13; 105(19):1408-9; discussion 1409. PubMed ID: 18574983
[No Abstract] [Full Text] [Related]
19. [MSD and LIF on marketing studies: all clinical trials can be used in marketing].
Bernadotte K; Bergström R
Lakartidningen; 2008 Sep 17-23; 105(38):2594-5; author reply 2595. PubMed ID: 18846867
[No Abstract] [Full Text] [Related]
20. [The LIFE study: extensive marketing in Denmark. Suggestions to conclusions based on the study].
Lindberg M
Lakartidningen; 2002 May; 99(20):2324. PubMed ID: 12082955
[No Abstract] [Full Text] [Related]
[Next] [New Search]
